FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2096751726> ?p ?o ?g. }

• W2096751726 endingPage "5501" @default.
• W2096751726 startingPage "5493" @default.
• W2096751726 abstract "Abstract The blockade of immune suppression against antitumor responses is a particularly attractive strategy when combined with agents that promote tumor-specific CTLs. In this study, we have attempted to further improve the CTL induction and potent antitumor efficacy of a combination mAb-based therapy (termed “trimAb therapy”) that comprises tumor cell death-inducing anti-death receptor 5 mAb and immune activating anti-CD40 and anti-CD137 mAbs. Among trimAb-treated tumors, the infiltration of CD4+ Foxp3+ cells was greater in progressing tumors compared with stable tumors. Blockade of CTLA-4 (CD152)-mediated signals by an antagonistic mAb substantially increased the tumor rejection rate of trimAb therapy, although the immune responses of draining lymph node cells were not augmented. Interestingly, by comparison, additional treatment with agonistic anti-glucocorticoid-induced TNF receptor mAb, antagonistic anti-programmed death-1 (CD279) mAb, or agonistic anti-OX40 (CD134) mAb significantly augmented immune responses of draining lymph node cells, but did not augment the therapeutic effect of trimAb. CD4 T cell depletion reduced the antitumor effect of anti–CTLA-4 mAb treatment alone, but did not reduce the tumor rejection rate of trimAb in conjunction with anti–CTLA-4 mAb. Thus, the blockade of the CTLA-4–mediated inhibitory signal in tumor infiltrating CTL may be the most effective strategy to augment the effect of immune therapies that generate tumor-specific CTL." @default.
• W2096751726 created "2016-06-24" @default.
• W2096751726 creator A5007330428 @default.
• W2096751726 creator A5012119811 @default.
• W2096751726 creator A5020297795 @default.
• W2096751726 creator A5046418468 @default.
• W2096751726 creator A5061575707 @default.
• W2096751726 creator A5070494006 @default.
• W2096751726 creator A5074513079 @default.
• W2096751726 creator A5085228147 @default.
• W2096751726 creator A5087829407 @default.
• W2096751726 creator A5088986458 @default.
• W2096751726 date "2010-05-15" @default.
• W2096751726 modified "2023-10-10" @default.
• W2096751726 title "Combination Therapy of Established Tumors by Antibodies Targeting Immune Activating and Suppressing Molecules" @default.
• W2096751726 cites W1517049862 @default.
• W2096751726 cites W1609716101 @default.
• W2096751726 cites W1870078228 @default.
• W2096751726 cites W1936607706 @default.
• W2096751726 cites W1973502859 @default.
• W2096751726 cites W1978354618 @default.
• W2096751726 cites W1981528932 @default.
• W2096751726 cites W1984510765 @default.
• W2096751726 cites W1996874641 @default.
• W2096751726 cites W1998006783 @default.
• W2096751726 cites W2002157461 @default.
• W2096751726 cites W2004150448 @default.
• W2096751726 cites W2013043293 @default.
• W2096751726 cites W2026426963 @default.
• W2096751726 cites W2031626045 @default.
• W2096751726 cites W2038475311 @default.
• W2096751726 cites W2048073154 @default.
• W2096751726 cites W2053737749 @default.
• W2096751726 cites W2053829861 @default.
• W2096751726 cites W2057499380 @default.
• W2096751726 cites W2061071534 @default.
• W2096751726 cites W2061982934 @default.
• W2096751726 cites W2062005611 @default.
• W2096751726 cites W2063264144 @default.
• W2096751726 cites W2063417695 @default.
• W2096751726 cites W2070443202 @default.
• W2096751726 cites W2073310925 @default.
• W2096751726 cites W2088422105 @default.
• W2096751726 cites W2105372977 @default.
• W2096751726 cites W2114601875 @default.
• W2096751726 cites W2116169737 @default.
• W2096751726 cites W2122584026 @default.
• W2096751726 cites W2128534029 @default.
• W2096751726 cites W2134907223 @default.
• W2096751726 cites W2140460887 @default.
• W2096751726 cites W2144037068 @default.
• W2096751726 cites W2154280336 @default.
• W2096751726 cites W2156106286 @default.
• W2096751726 cites W2156222101 @default.
• W2096751726 cites W2156441288 @default.
• W2096751726 cites W2156657486 @default.
• W2096751726 cites W2161888789 @default.
• W2096751726 cites W2163825883 @default.
• W2096751726 cites W2165639314 @default.
• W2096751726 cites W2171026458 @default.
• W2096751726 cites W2783142245 @default.
• W2096751726 cites W3022224433 @default.
• W2096751726 cites W4239710358 @default.
• W2096751726 doi "https://doi.org/10.4049/jimmunol.0903033" @default.
• W2096751726 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/20400706" @default.
• W2096751726 hasPublicationYear "2010" @default.
• W2096751726 type Work @default.
• W2096751726 sameAs 2096751726 @default.
• W2096751726 citedByCount "75" @default.
• W2096751726 countsByYear W20967517262012 @default.
• W2096751726 countsByYear W20967517262013 @default.
• W2096751726 countsByYear W20967517262014 @default.
• W2096751726 countsByYear W20967517262015 @default.
• W2096751726 countsByYear W20967517262016 @default.
• W2096751726 countsByYear W20967517262017 @default.
• W2096751726 countsByYear W20967517262018 @default.
• W2096751726 countsByYear W20967517262019 @default.
• W2096751726 countsByYear W20967517262020 @default.
• W2096751726 countsByYear W20967517262021 @default.
• W2096751726 countsByYear W20967517262022 @default.
• W2096751726 countsByYear W20967517262023 @default.
• W2096751726 crossrefType "journal-article" @default.
• W2096751726 hasAuthorship W2096751726A5007330428 @default.
• W2096751726 hasAuthorship W2096751726A5012119811 @default.
• W2096751726 hasAuthorship W2096751726A5020297795 @default.
• W2096751726 hasAuthorship W2096751726A5046418468 @default.
• W2096751726 hasAuthorship W2096751726A5061575707 @default.
• W2096751726 hasAuthorship W2096751726A5070494006 @default.
• W2096751726 hasAuthorship W2096751726A5074513079 @default.
• W2096751726 hasAuthorship W2096751726A5085228147 @default.
• W2096751726 hasAuthorship W2096751726A5087829407 @default.
• W2096751726 hasAuthorship W2096751726A5088986458 @default.
• W2096751726 hasBestOaLocation W20967517261 @default.
• W2096751726 hasConcept C126322002 @default.
• W2096751726 hasConcept C147969180 @default.
• W2096751726 hasConcept C159654299 @default.
• W2096751726 hasConcept C167672396 @default.
• W2096751726 hasConcept C170493617 @default.

• next